146 related articles for article (PubMed ID: 3529370)
1. Patients with primary Sjögren's syndrome treated for two months with evening primrose oil.
Oxholm P; Manthorpe R; Prause JU; Horrobin D
Scand J Rheumatol; 1986; 15(2):103-8. PubMed ID: 3529370
[TBL] [Abstract][Full Text] [Related]
2. Primary Sjögren's syndrome treated with Efamol/Efavit. A double-blind cross-over investigation.
Manthorpe R; Hagen Petersen S; Prause JU
Rheumatol Int; 1984; 4(4):165-7. PubMed ID: 6385206
[TBL] [Abstract][Full Text] [Related]
3. Essential fatty acid and prostaglandin metabolism in Sjögren's syndrome, systemic sclerosis and rheumatoid arthritis.
Horrobin DF
Scand J Rheumatol Suppl; 1986; 61():242-5. PubMed ID: 3296151
[TBL] [Abstract][Full Text] [Related]
4. Primary Sjögren's syndrome treated with Efamol/efavit. A double-blind cross-over investigation.
Webb J; McCredie M
Rheumatol Int; 1985; 5(4):191. PubMed ID: 4048763
[No Abstract] [Full Text] [Related]
5. Gammalinolenic acid treatment of fatigue associated with primary Sjögren's syndrome.
Theander E; Horrobin DF; Jacobsson LT; Manthorpe R
Scand J Rheumatol; 2002; 31(2):72-9. PubMed ID: 12109650
[TBL] [Abstract][Full Text] [Related]
6. A study of evening primrose seed oil in atopic asthma.
Ebden P; Bevan C; Banks J; Fennerty A; Walters EH
Prostaglandins Leukot Essent Fatty Acids; 1989 Feb; 35(2):69-72. PubMed ID: 2717651
[TBL] [Abstract][Full Text] [Related]
7. The influence of dietary marine oil (Polepa) and evening primrose oil (Efamol) on prostaglandin production by the rat mesenteric vasculature.
Nassar BA; Manku MS; Huang YS; Jenkins DK; Horrobin DF
Prostaglandins Leukot Med; 1987 Mar; 26(3):253-63. PubMed ID: 3033691
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Sjögren's syndrome: an overview.
Manthorpe R; Prause JU
Scand J Rheumatol Suppl; 1986; 61():237-41. PubMed ID: 3296150
[TBL] [Abstract][Full Text] [Related]
9. Effect of different ratios of dietary N-6 and N-3 fatty acids on fatty acid composition, prostaglandin formation and platelet aggregation in the rat.
Takahashi R; Nassar BA; Huang YS; Begin ME; Horrobin DF
Thromb Res; 1987 Jul; 47(2):135-46. PubMed ID: 3660347
[TBL] [Abstract][Full Text] [Related]
10. Evening primrose oil (Efamol) in the treatment of children with atopic eczema.
Bordoni A; Biagi PL; Masi M; Ricci G; Fanelli C; Patrizi A; Ceccolini E
Drugs Exp Clin Res; 1988; 14(4):291-7. PubMed ID: 3048953
[TBL] [Abstract][Full Text] [Related]
11. The effects of essential fatty acid supplementation by Efamol in hyperactive children.
Aman MG; Mitchell EA; Turbott SH
J Abnorm Child Psychol; 1987 Mar; 15(1):75-90. PubMed ID: 3553274
[TBL] [Abstract][Full Text] [Related]
12. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients.
Aragona P; Bucolo C; Spinella R; Giuffrida S; Ferreri G
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4474-9. PubMed ID: 16303936
[TBL] [Abstract][Full Text] [Related]
13. Effects of gammalinolenic acid on plasma lipoproteins and apolipoproteins.
Ishikawa T; Fujiyama Y; Igarashi O; Morino M; Tada N; Kagami A; Sakamoto T; Nagano M; Nakamura H
Atherosclerosis; 1989 Feb; 75(2-3):95-104. PubMed ID: 2540757
[TBL] [Abstract][Full Text] [Related]
14. Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins.
Schalin-Karrila M; Mattila L; Jansen CT; Uotila P
Br J Dermatol; 1987 Jul; 117(1):11-9. PubMed ID: 3307886
[TBL] [Abstract][Full Text] [Related]
15. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids).
Bamford JT; Gibson RW; Renier CM
J Am Acad Dermatol; 1985 Dec; 13(6):959-65. PubMed ID: 3908514
[TBL] [Abstract][Full Text] [Related]
16. Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double blind study.
Belch JJ; Shaw B; O'Dowd A; Saniabadi A; Leiberman P; Sturrock RD; Forbes CD
Thromb Haemost; 1985 Aug; 54(2):490-4. PubMed ID: 4082084
[TBL] [Abstract][Full Text] [Related]
17. Mucosolvan in the treatment of patients with primary Sjögren's syndrome. Results from a double-blind cross-over investigation.
Manthorpe R; Petersen SH; Prause JU
Acta Ophthalmol (Copenh); 1984 Aug; 62(4):537-41. PubMed ID: 6385607
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients.
Yoshimoto-Furuie K; Yoshimoto K; Tanaka T; Saima S; Kikuchi Y; Shay J; Horrobin DF; Echizen H
Nephron; 1999 Feb; 81(2):151-9. PubMed ID: 9933750
[TBL] [Abstract][Full Text] [Related]
19. A long-term study on the use of evening primrose oil (Efamol) in atopic children.
Biagi PL; Bordoni A; Masi M; Ricci G; Fanelli C; Patrizi A; Ceccolini E
Drugs Exp Clin Res; 1988; 14(4):285-90. PubMed ID: 3048952
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid and prostaglandin metabolism in children with diabetes mellitus. II. The effect of evening primrose oil supplementation on serum fatty acid and plasma prostaglandin levels.
Arisaka M; Arisaka O; Yamashiro Y
Prostaglandins Leukot Essent Fatty Acids; 1991 Jul; 43(3):197-201. PubMed ID: 1871184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
